Introduction Sexual function can be impaired by all prostate cancer treatment modalities, but
studies specifically addressing the impact of stereotactic body radiotherapy (SBRT) on …

Prostate cancer is the most common non-cutaneous cancer in males. There are a number of
options for patients with localized early stage disease, including active surveillance for low …

Background and purpose To determine appropriate risk-stratification factors for prostate
cancer patients undergoing stereotactic body radiotherapy (SBRT). Materials and methods …

Background Currently, there is no standard option for local salvage treatment for local
prostate cancer recurrence after radiotherapy. Our objective was to investigate the feasibility …

Background and purpose The optimal dose for prostate stereotactic body radiotherapy
(SBRT) is still unknown. This study evaluated the dose–response relationships for prostate …

Purpose External beam radiotherapy (EBRT) is an effective treatment option for low-and
favorable intermediate-risk prostate cancer (PCa) and it is usually delivered in conventional …

Background and purpose Stereotactic body radiation therapy (SBRT), low dose rate
brachytherapy (LDR-BT) and high dose rate brachytherapy (HDR-BT) are ablative-intent …

Purpose Understanding prostate-specific antigen (PSA) kinetics after radiation therapy plays
a large role in the management of patients with prostate cancer (PCa). This is particularly …

Prostate cancer can be managed with external beam radiation therapy, delivered with either
protons or photons, brachytherapy, surgery, or active surveillance. Advances in imaging and …

Purpose Low-dose-rate (LDR) brachytherapy and stereotactic body radiation therapy
(SBRT) have both shown acceptable outcomes in the treatment of low-and intermediate-risk …